Similarly, in Rhesus monkeys with toxin-induced parkinsonism, GDNF administration significantly improved postural instability, rigidity, and bradykinesia, while also enhancing dopamine levels and increasing dopaminergic fiber density86. This evidence concerns the gene GDNF and Parkinson disease.